Deciphering the intrinsic dynamics of unphosphorylated IRAK4 kinase bound to type I and type II inhibitors

Vijayakumar Gosu1, Santanu Sasidharan2, Prakash Saudagar2

  • 1Department of Animal Biotechnology, Jeonbuk National University, Jeonju, 54896, Republic of Korea.

Insights

This study reveals the dynamic behavior of unphosphorylated IRAK4 (uIRAK4) when bound to inhibitors. Type II inhibitors caused structural changes and showed stronger binding, offering insights for designing new IRAK4-targeting drugs.

Area of Science:

  • Biochemistry and Molecular Biology
  • Structural Biology
  • Pharmacology

Background:

  • Interleukin-1 receptor-associated kinase 4 (IRAK4) is crucial for immune signaling pathways.
  • Previous research focused on phosphorylated IRAK4, leaving unphosphorylated forms understudied.
  • Understanding inhibitor interactions with unphosphorylated IRAK4 is key for drug development.

Purpose of the Study:

  • To investigate the intrinsic dynamics of unphosphorylated IRAK4 (uIRAK4) bound to type I and type II inhibitors.
  • To compare the stability and binding characteristics of inhibitor-bound uIRAK4 forms.
  • To elucidate the structural basis for IRAK4 inhibition by different inhibitor types.

Main Methods:

  • Molecular dynamics simulations of apo and inhibitor-bound uIRAK4 (1.5 μs total).
  • Analysis of system stability, folding, solvent surface area, and hydrogen bonds.
  • Binding free energy calculations and free energy landscape analysis.

Main Results:

  • All simulated systems were stable, but the type II inhibitor-bound uIRAK4 showed reduced compactness and increased solvent exposure.
  • Type II inhibitors exhibited stronger binding free energy compared to type I inhibitors.
  • Reorientation of the Phe330 side chain in the DFG motif was observed across all systems.

Conclusions:

  • The study provides novel insights into the dynamics of inhibitor-bound unphosphorylated IRAK4.
  • Structural deformations in the type II inhibitor-bound complex are linked to inhibitor length.
  • Findings can guide the rational design of more effective IRAK4-targeting therapeutic agents.

Related Concept Videos

Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.5K
Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
13.2K
Phosphoinositides and PIPs01:42

Phosphoinositides and PIPs

Phosphoinositides are a group of phospholipids containing a glycerol backbone with two fatty acid chains and a phosphate attached to a myoinositol sugar ring. The inositol head group extends into the cytoplasm, where it is modified by adding phosphate groups to form phosphatidylinositol phosphates or PIPs.
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
8.6K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
9.0K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.7K
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
8.5K